Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water-soluble drugs

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 68, Issue 2, 2008, Pages 289-297

  Shokri, Javad ^a   Ahmadi, Parinaz ^a   Rashidi, Parisa ^a   Shahsavari, Mahbobeh ^a   Rajabi Siahboomi, Ali ^b   Nokhodchi, Ali ^a,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Colorcon Inc ^*  (United States)

^c MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Controlled drug delivery; Indomethacin; Lag time; SEOP; Zero order release

Indexed keywords

CARBOMER; CARBOXYMETHYLCELLULOSE; CASTOR OIL; CELLULOSE ACETATE; DODECYL SULFATE SODIUM; GLYCEROL; HYDROXYPROPYLMETHYLCELLULOSE; INDOMETACIN; MACROGOL 20000; MACROGOL 300; MACROGOL 600; MACROGOL DERIVATIVE; POLYMER; POVIDONE; UNCLASSIFIED DRUG; WETTING AGENT;

ARTICLE; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHOBICITY; MEMBRANE PERMEABILITY; OSMOTIC PUMP; PH; SWELLABLE ELEMENTARY OSMOTIC PUMP; TABLET COMPRESSION; TABLET FORMULATION;

DRUG DELIVERY SYSTEMS; OSMOSIS; SOLUBILITY; WATER;

EID: 37849020129     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.06.006     Document Type: Article

References (22)

1. Speers M., and Bonnano C. Economic aspects of controlled drug delivery. In: Mathiowitz E. (Ed). Encyclopedia of Controlled Drug Delivery (1999), Wiley, New York 341-347
2. Verma R.K., Kaushal A.M., and Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int. J. Pharm. 263 (2003) 9-24
3. Liu L., Ku J., Khang G., Lee B., Rhee J.M., and Lee H.B. Nifedipine controlled delivery by sandwiched osmotic tablet system. J. Control. Release 68 (2000) 145-156
4. Makhija S.N., and Vavia P.R. Controlled porosity osmotic pump-based controlled release system of pseudoephedrine. J. Control. Release 89 (2003) 5-18
5. Santus G., and Baker R.W. Osmotic drug delivery: a review of the patent literature. J. Control. Release 35 (1995) 1-21
6. Verma R.K., Krishna D.M., and Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release 79 (2002) 7-27
7. Prabakaran D., Singh P., Kanaujia P., and Vyas S.P. Effects of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int. J. Pharm. 259 (2003) 173-179
8. F. Theeuwes, Osmotic system for delivering selected beneficial agents having varying degrees of solubility, US Patent No. 4111, (1978) 201.
9. R. Cortese, F. Theeuwes, Osmotic device with hydrogel driving member, US Patent No. 4327, (1982) 725.
10. P.S.L. Wong, B.L. Barclay, J.C. Deters, F. Theeuwes, Osmotic device for administering certain drugs, US Patent No. 4765, (1988) 989.
11. Zentner G.M., Rork G.S., and Himmelstein K.J. Osmotic flow through controlled porosity films: an approach to delivery of water soluble compounds. J. Control. Release 2 (1985) 217-229
12. Zentner G.M., McClelland G.A., and Sutton S.C. Controlled porosity solubility- and resin-modulated drug delivery systems for release of diltiazem hydrochloride. J. Control. Release 16 (1991) 237-244
13. Thombre A.G., Zentner G.M., and Himmelstein K.I. Mechanism of water transport in controlled porosity osmotic devices. J. Membr. Sci. 40 (1989) 279-310
14. Herbig S.M., Cardinal J.R., Kosrsmeyer R.W., and Smith K.L. Asymmetric-membrane tablet coating for osmotic drug delivery. J. Control. Release 35 (1995) 127-136
15. Thombre A.G., Cardinal J.R., DeNoto A.R., Herbig S.M., and Smith K.L. Asymmetric membrane capsules for osmotic drug delivery: I. Development of a manufacturing process. J. Control. Release 57 (1999) 55-64
16. Thombre A.G., Cardinal J.R., DeNoto A.R., Herbig S.M., and Smith K.L. Asymmetric membrane capsules for osmotic drug delivery: II. In vitro and in vivo drug release performance. J. Control. Release 57 (1999) 65-73
17. Thombre A.G., DeNoto A.R., and Gibbes D.C. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J. Control. Release 60 (1999) 333-341
18. Thombre A.G., Appel L.E., Chidlaw M.B., Daugherity P.D., Dumont F., LEvans L.A.F., and Sutton S.C. Osmotic drug delivery using swellable-core technology. J. Control. Release 94 (2004) 75-89
19. Verma R.K., and Garg S. Development and evaluation of osmotic controlled oral drug delivery system of glipzide. J. Control. Release 57 (2004) 513-525
20. Ozdemir N., and Sahin J. Design of a controlled release osmotic pump system of ibuprofen. Int. J. Pharm. 158 (1997) 91-97
21. Liu L., Khang G., Rhee J.M., and Lee H.B. Monolithic osmotic tablet system for nifedipine delivery. J. Control. Release 67 (2000) 309-322
22. Lu E.-X., Jiang Z.-Q., Zhang Q.-Z., and Jiang X.-G. A water-insoluble drug monolithic osmotic tablet system utilizing gum Arabic as an osmotic, suspending and expanding agent. J. Control. Release 92 (2003) 375-382